Much of today's tissue engineering depends on biodegradable but synthetic scaffolds for cells that will rebuild a piece of organ or tissue. Typically, the scaffolding is eventually destroyed by the body. Cytograft's woven tissues, however, seem to remain in the body and become populated with cells. "A long time ago we decided we were going to make strong tissues without any scaffolding," says Nicolas L'Heureux, Cytograft's cofounder and chief scientific officer. "Once you get it in the body, your body doesn't see it as foreign."
The company developed the "human textile" idea from earlier work using sheets of biological material to reconstruct blood vessels. Basically, researchers grow human skin cells in a culture flask under conditions that encourage the cells to lay down a sheet of what is known as extracellular matrix—a structural material produced by animal cells that makes up our connective tissue. Cytograft can harvest these sheets from the culture flasks and then roll them into tubes that become replacement blood vessels. Blood vessels produced in this manner are still being tested—but they have performed well, with no signs of rejection, in a few patients in Europe and South America.